• Blog
  • Chronic Low Back Pain Treatment Market Report

    Chronic Low Back Pain Treatment Market Report

    Chronic Low Back Pain Treatment Market Report
    Report code - SRHL198 Delivery - 2 Weeks
    Get Free Sample |
    Play Audio
    Listen
    Global Chronic Low Back Pain Treatment Marke, Trends, Forecast & Market Analysis
    See more...

    Impact of COVID-19 on Chronic Low Back Pain Treatment Market

    Covid-19 has impacted the market dynamics, competition, and global...

    See more...

    Impact of COVID-19 on Chronic Low Back Pain Treatment Market

    Covid-19 has impacted the market dynamics, competition, and global supply chain. The revenues have gone down in 2020 and may resume an uptrend gradually from 2021. Companies optimizing their operation and strategy will sustain and beat the competition.

    Note: The summary below might not have included insights on covid impact since we have large number of reports.

    Market Insights

    The Global Chronic Low Back Pain Treatment Market is projected to grow from USD 7.35 billion in 2020 to USD 9.78 billion by 2026 at a CAGR of over 4.9% during the forecast period.

    Figure: Global Chronic Low Back Pain Treatment Market Size, 2020-2026 (USD Billion)

    Chronic-Low-Back-Pain-Treatment-Market-Forecast

    Wish to get a free sample? Register Here

    What is Chronic low back pain?

    Chronic low back pain is referred to as pain that persists for around 12 weeks or longer, even after an underlying cause of acute low back pain or initial injury has been treated. Low back pain is highly common and most people have suffered it for once. The exact cause of lower back pain is typically unknown. Lower back pain that is for more than 3 months (long-term) is known as chronic low back pain. This pain generally originates from a disease, injury, or stress on different structures of the body, and pain is likely to vary considerably and can be felt as bone pain, nerve pain, or muscle pain.

    Key Players

    Key players operating in the global chronic low back pain treatment market are-

    • Johnson & Johnson Services Inc. (The U.S.),
    • Pfizer Inc. (The U.S.),
    • Sanofi (France),
    • Endo Pharmaceuticals Inc. (Ireland),
    • Merck & Co., Inc. (The U.S.),
    • Vertebral Technologies, Inc. (The U.S.),
    • Medtronic (Ireland),
    • Boston Scientific Corporation (The U.S.),
    • Braeburn Pharmaceuticals (The U.S.), and
    • Camurus (Sweden).

    Market Dynamics

    As per the National Institute of Neurological Disorders and Stroke, around 80 % of adults experience this form of low back pain at some phase in life.

    An upsurge in the occurrence of nerve cases and rising growth in the geriatric population are likely to augment the market growth. Moreover, growing healthcare awareness among developed and emerging countries, inactive lifestyles, and growing purchasing power of consumers promulgates the demand for chronic low back pain treatment. However, unavailability of proper medication and poor supply chain management are some of the restraining negatively affecting the market expansion.

    Segment Analysis

    Treatment Type Trends

    By treatment type, the chronic low back pain treatment market has been segmented into analgesic medication, nonsteroidal anti-inflammatory drugs, anticonvulsants, antidepressants, others.

    • Under these, the analgesic medication segment dominated the market in 2020 and is projected to register a healthy CAGR during the assessment period.
    • Analgesics are mainly developed to relieve pain.
    • These medications consist of prescription opioids such as morphine, hydrocodone, oxycodone, and codeine as well as OTC aspirin and acetaminophen.
    • The need to reduce lower back pain drives the demand for analgesics.

    Regional Trends

    By region, the North American market accounted for the largest market share in 2020 and is projected to grow at a steady CAGR during the forecast period.

    • This is mainly attributed to the growing awareness among the people regarding chronic lower back pain, high per capita income, rising prevalence of chronic lower back pain, and increasing emphasis on prevention of chronic lower back pain, thus augments the regional market growth.
    • Also, the highest diagnosed prevalence of chronic low back pain is in the U.S. with over 20 million cases in 2017.

    COVID-19 Impact on Global Chronic Low Back Pain Treatment Market

    The outbreak of the COVID-19 pandemic has adversely impacted the chronic low back pain treatment industry due to postponed appointments and strict social distance norms resulting in lesser treatment appointments. However, due to work from home policy, the employees are suffering from severe lower back pain due to poor sitting posture and absence of work furniture in many countries across the globe.

    Critical Questions Answered in the Report

    • What are the key trends in the global chronic low back pain treatment market?
    • How the market (and its various sub-segments) has grown in the last five years and what would be the growth rate in the next five years?
    • What is the impact of COVID-19 on the global chronic low back pain treatment market?
    • What are the key strategies adopted by the major vendors to lead in the global chronic low back pain treatment market?
    • What is the market share of the top vendors?

    Want to get the full scope of the report? Register Here

    Target Audience

    The following is a list of the customers that the Chronic Low Back Pain market aims to convert the most:

    • Chronic low back pain treatment companies
    • Hospitals
    • R&D centers
    • Pharmaceutical companies
    • Orthopedic Clinics

    Custom Research: Stratview research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at [email protected].

    Frequently Asked Questions (FAQs)

    The chronic low back pain treatment market size is expected to reach USD 9.78 billion in the foreseeable future.

    Johnson & Johnson Services Inc. (The U.S.), Pfizer Inc. (The U.S.), Sanofi (France), Endo Pharmaceuticals Inc. (Ireland), Merck & Co., Inc. (The U.S.), Vertebral Technologies, Inc. (The U.S.), Medtronic (Ireland), Boston Scientific Corporation (The U.S.), Braeburn Pharmaceuticals (The U.S.), and Camurus (Sweden) are among the key players in the chronic low back pain treatment market.

    The chronic low back pain treatment market is expected to witness an impressive growth of 4.9% CAGR in the coming years.

    An upsurge in the occurrence of nerve cases, rising growth in the geriatric population, growing healthcare awareness among developed and emerging countries, inactive lifestyles, and growing purchasing power of consumers are the factors driving the growth of chronic low back pain treatment market.

    North American market accounted for the largest market share in 2020 and is projected to grow at a steady CAGR during the forecast period.

    Analgesic medication segment dominated the market in 2020 and is projected to register a healthy CAGR during the assessment period.

    Chronic low back pain treatment companies, Hospitals, R&D centers, Pharmaceutical companies, Orthopedic Clinics are the target audience in the chronic low back pain treatment market.

    •